Entera Bio Ltd. (ENTX) vs Fortress Biotech, Inc. (FBIOP)
A side-by-side comparison of Entera Bio Ltd. and Fortress Biotech, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENTX
Entera Bio Ltd.
$2.55HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
FBIOP
Fortress Biotech, Inc.
$17.50HealthcareDelayed quote: Oct 6, 2026, 10:15 AM EDT
Total return — ENTX vs FBIOP
growth of $100 · dividends reinvested · last 8yENTX -58.3% (-10.4%/yr)FBIOP +74.9% (+7.2%/yr)FBIOP compounded faster over this window
ENTX FBIOP
ENTX vs FBIOP: by the numbers
- •FBIOP is the larger company ($138M vs $125M market cap).
- •FBIOP is profitable (163.32% net margin) while ENTX runs a net loss (-27235.71%).
Metrics side by side
Valuation
| Metric | ENTX | FBIOP |
|---|---|---|
| P/E ratio | N/A | 6.52 |
| Forward P/E | N/A | 6.86 |
| P/S ratio | N/A | 2.01 |
| P/B ratio | 17.26 | 0.84 |
| FCF yield | N/A | 91.34% |
Profitability
| Metric | ENTX | FBIOP |
|---|---|---|
| Gross margin | 0.00% | 62.53% |
| Operating margin | -27450.00% | -111.00% |
| Net margin | -27235.71% | 163.32% |
| ROE | -234.42% | 68.12% |
| ROIC | -82.87% | -10.85% |
Growth (annualized)
| Metric | ENTX | FBIOP |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 5.39% |
| Total return CAGR (5Y) | -10.57% | 0.05% |
Frequently asked
- Is ENTX or FBIOP more profitable?
- FBIOP runs the higher net margin — ENTX at -27235.71% versus FBIOP at 163.32%.
- How have ENTX and FBIOP total returns compared?
- Over the past 5 years, ENTX delivered -10.57% and FBIOP delivered 0.05% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Fortress Biotech P/E ratioEntera Bio ROEFortress Biotech ROEEntera Bio operating marginFortress Biotech operating marginEntera Bio revenue growthFortress Biotech revenue growthEntera Bio free cash flowFortress Biotech free cash flow
Entera Bio & Fortress Biotech appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.